Pre-exposure prophylaxis for men and transgender women who have sex with men in Brazil: opportunities and challenges

The World Health Organization recently released guidelines on the use of pre‐exposure prophylaxis (PrEP) for prevention of HIV infection among men and transgender women (TGW) who have sex with men based on results of randomized clinical trials. The aim of this commentary is to discuss the opportunities and challenges of incorporating PrEP into the Brazilian continuum of HIV care and prevention for men who have sex with men (MSM) and TGW.

[1]  Kimberly A. Koester,et al.  Client and Provider Perspectives on New HIV Prevention Tools for MSM in the Americas , 2015, PloS one.

[2]  R. Baggaley,et al.  Young key populations and HIV: a special emphasis and consideration in the new WHO Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations , 2015, Journal of the International AIDS Society.

[3]  W. Mcfarland,et al.  High HIV Prevalence among Men who have Sex with Men in a Time-Location Sampling Survey, São Paulo, Brazil , 2015, AIDS and Behavior.

[4]  Megha L Mehrotra,et al.  Patterns and Correlates of PrEP Drug Detection Among MSM and Transgender Women in the Global iPrEx Study , 2014, Journal of acquired immune deficiency syndromes.

[5]  Megha L Mehrotra,et al.  Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. , 2014, The Lancet. Infectious diseases.

[6]  David R. Holtgrave,et al.  HIV prevention in clinical care settings: 2014 recommendations of the International Antiviral Society-USA Panel. , 2014, JAMA.

[7]  Patrick S Sullivan,et al.  Acceptability of self-conducted home-based HIV testing among men who have sex with men in Brazil: data from an on-line survey. , 2014, Cadernos de saude publica.

[8]  R. D. De Boni,et al.  Epidemiology of HIV in Latin America and the Caribbean , 2014, Current opinion in HIV and AIDS.

[9]  C. Beyrer,et al.  Acceptability of Pre-Exposure Prophylaxis among Men Who Have Sex with Men and Transgender Women in Northern Thailand , 2013, PloS one.

[10]  C. Hendrix,et al.  Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial , 2013, The Lancet.

[11]  C. Kendall,et al.  Travestis, an unexplored population at risk of HIV in a large metropolis of northeast Brazil: A respondent-driven sampling survey , 2013, AIDS care.

[12]  C. Beyrer,et al.  Worldwide burden of HIV in transgender women: a systematic review and meta-analysis. , 2013, The Lancet. Infectious diseases.

[13]  A. Vassall,et al.  The Cost and Impact of Scaling Up Pre-exposure Prophylaxis for HIV Prevention: A Systematic Review of Cost-Effectiveness Modelling Studies , 2013, PLoS medicine.

[14]  C. Kendall,et al.  HIV among MSM in a large middle-income country , 2013, AIDS.

[15]  T. Hallett,et al.  Are Thai MSM Willing to Take PrEP for HIV Prevention? An Analysis of Attitudes, Preferences and Acceptance , 2013, PloS one.

[16]  L. Kerr,et al.  Unprotected Receptive Anal Intercourse Among Men Who have Sex with Men in Brazil , 2013, AIDS and Behavior.

[17]  S. Gruskin,et al.  The impacts of AIDS movements on the policy responses to HIV/AIDS in Brazil and South Africa: A comparative analysis , 2012, Global public health.

[18]  E. Gouws,et al.  Focusing the HIV response through estimating the major modes of HIV transmission: a multi-country analysis , 2012, Sexually Transmitted Infections.

[19]  G. Tillotson Faculty of 1000 evaluation for Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. , 2012 .

[20]  Peter L. Anderson,et al.  Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with Men , 2012, Science Translational Medicine.

[21]  John T Brooks,et al.  Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. , 2012, The New England journal of medicine.

[22]  James D. Campbell,et al.  Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. , 2012, The New England journal of medicine.

[23]  Michael Rayment,et al.  Prevention of HIV-1 infection with early antiretroviral therapy , 2012, Journal of Family Planning and Reproductive Health Care.

[24]  M. Dybul,et al.  Attitudes and Acceptance of Oral and Parenteral HIV Preexposure Prophylaxis among Potential User Groups: A Multinational Study , 2012, PloS one.

[25]  J. Macinko,et al.  The Brazilian health system: history, advances, and challenges , 2011, The Lancet.

[26]  David V Glidden,et al.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. , 2010, The New England journal of medicine.

[27]  M. Golden,et al.  Awareness and use of HIV pre-exposure prophylaxis among attendees of a seattle gay pride event and sexually transmitted disease clinic. , 2010, AIDS patient care and STDs.

[28]  F. Bastos,et al.  Rio de Janeiro, Brazil , 2019, The Statesman’s Yearbook Companion.

[29]  A. E. H. Virais Recomendações para terapia antirretroviral em adultos infectados pelo HIV - 2008: suplemento III - tratamento e prevenção , 2010 .

[30]  S. Gruskin,et al.  AIDS treatment in Brazil: impacts and challenges. , 2009, Health affairs.

[31]  Kenneth H Mayer,et al.  Preexposure Antiretroviral Prophylaxis Attitudes in High-Risk Boston Area Men Who Report Having Sex With Men: Limited Knowledge and Experience but Potential for Increased Utilization After Education , 2009, Journal of acquired immune deficiency syndromes.

[32]  黄亚明,et al.  Journal of the International AIDS Society , 2017 .

[33]  J. Galvao Brazil and access to HIV/AIDS drugs: a question of human rights and public health. , 2005, American journal of public health.